Elsa Tretter

Elsa Tretter has a solid work experience in the biotech industry. Elsa is currently serving as the Director of Business Development at RAPT Therapeutics since September 2021. Prior to this, they worked at Nurix Therapeutics for nine years. During their time at Nurix, they held multiple roles, including Associate Director of Business Development, Alliance Management/Business Development Manager, Scientist II, Scientist, and Associate Scientist. Elsa's extensive experience demonstrates their expertise and growth within the biotech field.

Elsa Tretter completed their Bachelor of Science (BS) degree in Biochemistry & Molecular Biology from the University of California, Davis, from 2003 to 2007. Following this, they pursued their doctoral degree (PhD) in Biochemistry and Molecular Biology at the University of California, Berkeley, from 2007 to 2012. Currently, they are enrolled in The Wharton School, where they are working towards obtaining a Master of Business Administration (MBA) degree, with a completion expected in 2023.